Q9NSY1 (BMP2K_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Names and origin

Protein names

Recommended name:
BMP-2-inducible protein kinase
Short name=BIKe
EC=2.7.11.1

Gene names

Name:	BMP2K
Synonyms:	BIKE
ORF Names:	HRIHFB2017

Organism

Homo sapiens (Human)

Taxonomic identifier

9606 [NCBI]

Taxonomic lineage

Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo

Protein attributes

Sequence length	1161 AA.
Sequence status	Complete.
Protein existence	Evidence at protein level

General annotation (Comments)

Function	May be involved in osteoblast differentiation.
Catalytic activity	ATP + a protein = ADP + a phosphoprotein.
Subcellular location	Nucleus Ref.5.
Post-translational modification	Autophosphorylated By similarity. Ref.6 Ref.7 Ref.8 Ref.9 Ref.10
Sequence similarities	Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. Contains 1 protein kinase domain.

Ontologies

Keywords
Cellular component	Nucleus
Coding sequence diversity	Alternative splicing Polymorphism
Ligand	ATP-binding Nucleotide-binding
Molecular function	Kinase Serine/threonine-protein kinase Transferase
PTM	Phosphoprotein
Technical term	Complete proteome Reference proteome
Gene Ontology (GO)
Cellular component	nucleus Inferred from direct assay. Source: HPA
Molecular function	ATP binding Inferred from electronic annotation. Source: UniProtKB-KW protein serine/threonine kinase activity Inferred from electronic annotation. Source: UniProtKB-KW
Complete GO annotation...

Alternative products

This entry describes 3 isoforms produced by alternative splicing. [Align] [Select]

Isoform 1 (identifier: Q9NSY1-1)

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.

Isoform 2 (identifier: Q9NSY1-2)

The sequence of this isoform differs from the canonical sequence as follows:
     651-662: NRLEERASSDKN → SKGHLKAYFASQ
     663-1161: Missing.

Isoform 3 (identifier: Q9NSY1-3)

The sequence of this isoform differs from the canonical sequence as follows:
     330-340: NSSIPSALPEP → KCCKQLLRHGALLTEILLFLQLFLNR
     651-662: NRLEERASSDKN → SKGHLKAYFASQ
     663-1161: Missing.

Note: No experimental confirmation available.

Sequence annotation (Features)

	Feature key	Position(s)	Length	Description	Graphical view	Feature identifier
Molecule processing
	Chain	1 – 1161	1161	BMP-2-inducible protein kinase		PRO_0000085663
Regions
	Domain	51 – 316	266	Protein kinase
	Nucleotide binding	57 – 65	9	ATP By similarity
	Compositional bias	12 – 40	29	Gly-rich
	Compositional bias	425 – 559	135	Gln/His-rich
Sites
	Active site	180	1	Proton acceptor By similarity
	Binding site	79	1	ATP By similarity
Amino acid modifications
	Modified residue	10	1	Phosphoserine Ref.9
	Modified residue	14	1	Phosphoserine Ref.9
	Modified residue	378	1	Phosphoserine Ref.9
	Modified residue	665	1	Phosphoserine Ref.9
	Modified residue	680	1	Phosphoserine Ref.9
	Modified residue	685	1	Phosphoserine Ref.9
	Modified residue	728	1	Phosphoserine Ref.9
	Modified residue	824	1	Phosphoserine Ref.7 Ref.9
	Modified residue	826	1	Phosphoserine Ref.7
	Modified residue	942	1	Phosphothreonine Ref.9
	Modified residue	947	1	Phosphoserine Ref.8 Ref.9
	Modified residue	979	1	Phosphoserine Ref.7
	Modified residue	1002	1	Phosphothreonine Ref.7
	Modified residue	1011	1	Phosphothreonine Ref.7
	Modified residue	1029	1	Phosphoserine Ref.7 Ref.9 Ref.10
	Modified residue	1031	1	Phosphoserine Ref.7 Ref.9
	Modified residue	1032	1	Phosphoserine Ref.7 Ref.9 Ref.10
	Modified residue	1041	1	Phosphoserine Ref.7
	Modified residue	1076	1	Phosphoserine Ref.7
	Modified residue	1107	1	Phosphoserine Ref.6 Ref.7 Ref.9
	Modified residue	1111	1	Phosphoserine Ref.7 Ref.9
Natural variations
	Alternative sequence	330 – 340	11	NSSIPSALPEP → KCCKQLLRHGALLTEILLFL QLFLNR in isoform 3.		VSP_008093
	Alternative sequence	651 – 662	12	NRLEE…SSDKN → SKGHLKAYFASQ in isoform 2 and isoform 3.		VSP_008091
	Alternative sequence	663 – 1161	499	Missing in isoform 2 and isoform 3.		VSP_008092
	Natural variant	68	1	V → M in a lung squamous cell carcinoma sample; somatic mutation. Ref.12		VAR_040388
	Natural variant	212	1	D → V. Ref.12		VAR_040389
	Natural variant	288	1	R → H. Ref.12		VAR_040390
	Natural variant	405	1	G → S. Ref.3 Corresponds to variant rs2288255 [ dbSNP | Ensembl ].		VAR_051618
	Natural variant	486	1	Q → H. Corresponds to variant rs2114202 [ dbSNP | Ensembl ].		VAR_059765
	Natural variant	1002	1	T → S. Corresponds to variant rs12507099 [ dbSNP | Ensembl ].		VAR_051619
Experimental info
	Sequence conflict	342	1	T → A in AAH36021. Ref.3
	Sequence conflict	471 – 486	16	Missing in CAB70863. Ref.2
	Sequence conflict	478	1	Q → R in AAH36021. Ref.3

Sequences

	Sequence		Length	Mass (Da)
	Isoform 1 [UniParc]. Last modified August 22, 2003. Version 2. Checksum: 5C38A86E95935EC2	FASTA	1,161	129,172
	10 20 30 40 50 60 MKKFSRMPKS EGGSGGGAAG GGAGGAGAGA GCGSGGSSVG VRVFAVGRHQ VTLEESLAEG 70 80 90 100 110 120 GFSTVFLVRT HGGIRCALKR MYVNNMPDLN VCKREITIMK ELSGHKNIVG YLDCAVNSIS 130 140 150 160 170 180 DNVWEVLILM EYCRAGQVVN QMNKKLQTGF TEPEVLQIFC DTCEAVARLH QCKTPIIHRD 190 200 210 220 230 240 LKVENILLND GGNYVLCDFG SATNKFLNPQ KDGVNVVEEE IKKYTTLSYR APEMINLYGG 250 260 270 280 290 300 KPITTKADIW ALGCLLYKLC FFTLPFGESQ VAICDGNFTI PDNSRYSRNI HCLIRFMLEP 310 320 330 340 350 360 DPEHRPDIFQ VSYFAFKFAK KDCPVSNINN SSIPSALPEP MTASEAAARK SQIKARITDT 370 380 390 400 410 420 IGPTETSIAP RQRPKANSAT TATPSVLTIQ SSATPVKVLA PGEFGNHRPK GALRPGNGPE 430 440 450 460 470 480 ILLGQGPPQQ PPQQHRVLQQ LQQGDWRLQQ LHLQHRHPHQ QQQQQQQQQQ QQQQQQQQQQ 490 500 510 520 530 540 QQQQQQHHHH HHHHLLQDAY MQQYQHATQQ QQMLQQQFLM HSVYQPQPSA SQYPTMMPQY 550 560 570 580 590 600 QQAFFQQQML AQHQPSQQQA SPEYLTSPQE FSPALVSYTS SLPAQVGTIM DSSYSANRSV 610 620 630 640 650 660 ADKEAIANFT NQKNISNPPD MSGWNPFGED NFSKLTEEEL LDREFDLLRS NRLEERASSD 670 680 690 700 710 720 KNVDSLSAPH NHPPEDPFGS VPFISHSGSP EKKAEHSSIN QENGTANPIK NGKTSPASKD 730 740 750 760 770 780 QRTGKKTSVQ GQVQKGNDES ESDFESDPPS PKSSEEEEQD DEEVLQGEQG DFNDDDTEPE 790 800 810 820 830 840 NLGHRPLLMD SEDEEEEEKH SSDSDYEQAK AKYSDMSSVY RDRSGSGPTQ DLNTILLTSA 850 860 870 880 890 900 QLSSDVAVET PKQEFDVFGA VPFFAVRAQQ PQQEKNEKNL PQHRFPAAGL EQEEFDVFTK 910 920 930 940 950 960 APFSKKVNVQ ECHAVGPEAH TIPGYPKSVD VFGSTPFQPF LTSTSKSESN EDLFGLVPFD 970 980 990 1000 1010 1020 EITGSQQQKV KQRSLQKLSS RQRRTKQDMS KSNGKRHHGT PTSTKKTLKP TYRTPERARR 1030 1040 1050 1060 1070 1080 HKKVGRRDSQ SSNEFLTISD SKENISVALT DGKDRGNVLQ PEESLLDPFG AKPFHSPDLS 1090 1100 1110 1120 1130 1140 WHPPHQGLSD IRADHNTVLP GRPRQNSLHG SFHSADVLKM DDFGAVPFTE LVVQSITPHQ 1150 1160 SQQSQPVELD PFGAAPFPSK Q
	Isoform 2 [UniParc]. Checksum: ED443E4DC0696FF3	FASTA	662	73,838
	10 20 30 40 50 60 MKKFSRMPKS EGGSGGGAAG GGAGGAGAGA GCGSGGSSVG VRVFAVGRHQ VTLEESLAEG 70 80 90 100 110 120 GFSTVFLVRT HGGIRCALKR MYVNNMPDLN VCKREITIMK ELSGHKNIVG YLDCAVNSIS 130 140 150 160 170 180 DNVWEVLILM EYCRAGQVVN QMNKKLQTGF TEPEVLQIFC DTCEAVARLH QCKTPIIHRD 190 200 210 220 230 240 LKVENILLND GGNYVLCDFG SATNKFLNPQ KDGVNVVEEE IKKYTTLSYR APEMINLYGG 250 260 270 280 290 300 KPITTKADIW ALGCLLYKLC FFTLPFGESQ VAICDGNFTI PDNSRYSRNI HCLIRFMLEP 310 320 330 340 350 360 DPEHRPDIFQ VSYFAFKFAK KDCPVSNINN SSIPSALPEP MTASEAAARK SQIKARITDT 370 380 390 400 410 420 IGPTETSIAP RQRPKANSAT TATPSVLTIQ SSATPVKVLA PGEFGNHRPK GALRPGNGPE 430 440 450 460 470 480 ILLGQGPPQQ PPQQHRVLQQ LQQGDWRLQQ LHLQHRHPHQ QQQQQQQQQQ QQQQQQQQQQ 490 500 510 520 530 540 QQQQQQHHHH HHHHLLQDAY MQQYQHATQQ QQMLQQQFLM HSVYQPQPSA SQYPTMMPQY 550 560 570 580 590 600 QQAFFQQQML AQHQPSQQQA SPEYLTSPQE FSPALVSYTS SLPAQVGTIM DSSYSANRSV 610 620 630 640 650 660 ADKEAIANFT NQKNISNPPD MSGWNPFGED NFSKLTEEEL LDREFDLLRS SKGHLKAYFA SQ
	Isoform 3 [UniParc]. Checksum: FF17E464DB5F952C	FASTA	677	75,812
	10 20 30 40 50 60 MKKFSRMPKS EGGSGGGAAG GGAGGAGAGA GCGSGGSSVG VRVFAVGRHQ VTLEESLAEG 70 80 90 100 110 120 GFSTVFLVRT HGGIRCALKR MYVNNMPDLN VCKREITIMK ELSGHKNIVG YLDCAVNSIS 130 140 150 160 170 180 DNVWEVLILM EYCRAGQVVN QMNKKLQTGF TEPEVLQIFC DTCEAVARLH QCKTPIIHRD 190 200 210 220 230 240 LKVENILLND GGNYVLCDFG SATNKFLNPQ KDGVNVVEEE IKKYTTLSYR APEMINLYGG 250 260 270 280 290 300 KPITTKADIW ALGCLLYKLC FFTLPFGESQ VAICDGNFTI PDNSRYSRNI HCLIRFMLEP 310 320 330 340 350 360 DPEHRPDIFQ VSYFAFKFAK KDCPVSNINK CCKQLLRHGA LLTEILLFLQ LFLNRMTASE 370 380 390 400 410 420 AAARKSQIKA RITDTIGPTE TSIAPRQRPK ANSATTATPS VLTIQSSATP VKVLAPGEFG 430 440 450 460 470 480 NHRPKGALRP GNGPEILLGQ GPPQQPPQQH RVLQQLQQGD WRLQQLHLQH RHPHQQQQQQ 490 500 510 520 530 540 QQQQQQQQQQ QQQQQQQQQQ QHHHHHHHHL LQDAYMQQYQ HATQQQQMLQ QQFLMHSVYQ 550 560 570 580 590 600 PQPSASQYPT MMPQYQQAFF QQQMLAQHQP SQQQASPEYL TSPQEFSPAL VSYTSSLPAQ 610 620 630 640 650 660 VGTIMDSSYS ANRSVADKEA IANFTNQKNI SNPPDMSGWN PFGEDNFSKL TEEELLDREF 670 DLLRSSKGHL KAYFASQ

References

[1]	"Complete sequencing and characterization of 21,243 full-length human cDNAs." Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S. Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2). Tissue: Thyroid.
[2]	"The full-ORF clone resource of the German cDNA consortium." Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I. BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3). Tissue: Testis.
[3]	"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), VARIANT SER-405. Tissue: Testis.
[4]	Guo J.H., Yu L. Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 537-1161 (ISOFORM 2). Tissue: Ovary.
[5]	"Selection system for genes encoding nuclear-targeted proteins." Ueki N., Oda T., Kondo M., Yano K., Noguchi T., Muramatsu M.-A. Nat. Biotechnol. 16:1338-1342(1998) [PubMed: 9853615] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 946-1161 (ISOFORM 1), SUBCELLULAR LOCATION. Tissue: Brain.
[6]	"Global, in vivo, and site-specific phosphorylation dynamics in signaling networks." Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M. Cell 127:635-648(2006) [PubMed: 17081983] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1107, MASS SPECTROMETRY. Tissue: Cervix carcinoma.
[7]	"Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle." Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Mol. Cell 31:438-448(2008) [PubMed: 18691976] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-824; SER-826; SER-979; THR-1002; THR-1011; SER-1029; SER-1031; SER-1032; SER-1041; SER-1076; SER-1107 AND SER-1111, MASS SPECTROMETRY. Tissue: Cervix carcinoma.
[8]	"Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach." Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S. Anal. Chem. 81:4493-4501(2009) [PubMed: 19413330] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-947, MASS SPECTROMETRY. Tissue: Embryonic kidney.
[9]	"Large-scale proteomics analysis of the human kinome." Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H. Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed: 19369195] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-10; SER-14; SER-378; SER-665; SER-680; SER-685; SER-728; SER-824; THR-942; SER-947; SER-1029; SER-1031; SER-1032; SER-1107 AND SER-1111, MASS SPECTROMETRY.
[10]	"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1029 AND SER-1032, MASS SPECTROMETRY. Tissue: Leukemic T-cell.
[11]	"Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed: 21269460] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
[12]	"Patterns of somatic mutation in human cancer genomes." Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G. , Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R. Nature 446:153-158(2007) [PubMed: 17344846] [Abstract] Cited for: VARIANTS [LARGE SCALE ANALYSIS] MET-68; VAL-212 AND HIS-288.
+	Additional computationally mapped references.

Cross-references

Sequence databases
EMBL GenBank DDBJ	AK075278 mRNA. Translation: BAC11515.1. AL137275 mRNA. Translation: CAB70673.1. AL137661 mRNA. Translation: CAB70863.1. BC036021 mRNA. Translation: AAH36021.1. AF527532 mRNA. Translation: AAM88867.1. AB015331 mRNA. Translation: BAA34790.1.
IPI	IPI00033606. IPI00337426. IPI00412057.
PIR	T46347. T46364.
RefSeq	NP_060063.2. NM_017593.3. NP_942595.1. NM_198892.1.
UniGene	Hs.146551.
3D structure databases
ProteinModelPortal	Q9NSY1.
SMR	Q9NSY1. Positions 40-319.
ModBase	Search...
Protein-protein interaction databases
IntAct	Q9NSY1. 2 interactions.
STRING	Q9NSY1.
PTM databases
PhosphoSite	Q9NSY1.
Polymorphism databases
DMDM	34222653.
Proteomic databases
PRIDE	Q9NSY1.
Protocols and materials databases
StructuralBiologyKnowledgebase	Search...
Genome annotation databases
Ensembl	ENST00000335016; ENSP00000334836; ENSG00000138756.
GeneID	55589.
KEGG	hsa:55589.
UCSC	uc003hlj.1. human. uc003hlk.1. human.
Organism-specific databases
CTD	55589.
GeneCards	GC04P079697.
HGNC	HGNC:18041. BMP2K.
HPA	HPA026436. HPA026451. HPA026501.
neXtProt	NX_Q9NSY1.
GenAtlas	Search...
Phylogenomic databases
eggNOG	prNOG13143.
GeneTree	ENSGT00510000046552.
HOGENOM	HBG283730.
HOVERGEN	HBG050703.
InParanoid	Q9NSY1.
OMA	RRPDIFQ.
PhylomeDB	Q9NSY1.
Gene expression databases
ArrayExpress	Q9NSY1.
Bgee	Q9NSY1.
CleanEx	HS_BMP2K.
Genevestigator	Q9NSY1.
GermOnline	ENSG00000138756. Homo sapiens.
Family and domain databases
InterPro	IPR011009. Kinase-like_dom. IPR000719. Prot_kinase_cat_dom. IPR017442. Se/Thr_kinase-like_dom. IPR008271. Ser/Thr_kinase_AS. [Graphical view]
KO	K08854.
Pfam	PF00069. Pkinase. 1 hit. [Graphical view]
SUPFAM	SSF56112. Kinase_like. 1 hit.
PROSITE	PS00107. PROTEIN_KINASE_ATP. False negative. PS50011. PROTEIN_KINASE_DOM. 1 hit. PS00108. PROTEIN_KINASE_ST. 1 hit. [Graphical view]
ProtoNet	Search...
Other
NextBio	60112.

Entry information

Entry name

BMP2K_HUMAN

Accession

Primary (citable) accession number: Q9NSY1
Secondary accession number(s): O94791 , Q8IYF2, Q8N2G7, Q8NHG9, Q9NTG8

Entry history

Integrated into UniProtKB/Swiss-Prot:	August 22, 2003
Last sequence update:	August 22, 2003
Last modified:	January 25, 2012
This is version 100 of the entry and version 2 of the sequence. [Complete history]

Entry status

Reviewed (UniProtKB/Swiss-Prot)

Annotation program

Chordata Protein Annotation Program

Disclaimer

Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.